
Tomas Hajek
Tomas Hajek is a psychiatrist at Dalhousie University in Canada, known for his expertise in the therapeutic applications of lithium in mental health. He recently commented on the potential implications of lithium in treating Alzheimer's disease, reflecting on challenges within the pharmaceutical industry regarding the commercialization of lithium treatments due to its low cost and natural occurrence. Hajek's insights highlight the need for further research to validate the effectiveness of lithium in dementia care while addressing economic barriers in developing new therapies.
Not in the pool (under ¢1).
Recent news mentions
Tomas Hajek, a psychiatrist from Dalhousie University, notes that lithium is 'ridiculously cheap' and cannot be patented.
Litium suojaa Alzheimerin taudilta – Voisi toimia lääkkeenäTomas Hajek, a psychiatrist from Dalhousie University in Canada, noted that no pharmaceutical company will profit from lithium.
Descubren que la deficiencia de litio causa Alzheimer y logran revertir la pérdida de memoria en ratones


